RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 95 filers reported holding RELAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $800,767 | -27.8% | 95,216 | +7.9% | 0.00% | – |
| Q2 2023 | $1,108,520 | -35.5% | 88,258 | -15.5% | 0.00% | -100.0% |
| Q1 2023 | $1,719,419 | +36.1% | 104,397 | +23.6% | 0.00% | – |
| Q4 2022 | $1,263,000 | -33.8% | 84,477 | -0.9% | 0.00% | -100.0% |
| Q3 2022 | $1,908,000 | +33.9% | 85,283 | +0.3% | 0.00% | – |
| Q2 2022 | $1,425,000 | -34.8% | 85,056 | +16.4% | 0.00% | -100.0% |
| Q1 2022 | $2,186,000 | +9.7% | 73,054 | +12.6% | 0.00% | 0.0% |
| Q4 2021 | $1,993,000 | +46.4% | 64,898 | +50.3% | 0.00% | – |
| Q3 2021 | $1,361,000 | -6.0% | 43,175 | +9.1% | 0.00% | – |
| Q2 2021 | $1,448,000 | +15.1% | 39,591 | +8.8% | 0.00% | – |
| Q1 2021 | $1,258,000 | -31.7% | 36,386 | -17.9% | 0.00% | -100.0% |
| Q4 2020 | $1,841,000 | -5.7% | 44,313 | -3.3% | 0.00% | 0.0% |
| Q3 2020 | $1,953,000 | – | 45,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |